BioSpace News Archive

Adaptation Health, in partnership with Acumen America and the Center for Health Care Strategies announce the selected companies and panelists to a 3-part virtual demo day series: Responding to COVID-19 and Beyond: Demo Day for Medicaid Innovation.

Zoetis Inc. (NYSE:ZTS) will participate in the William Blair 40th Annual Growth Stock Conference on Thursday, June 11, 2020. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 12:20 p.m. ET (11:20 a.m. CT). Investors and other interested parties will be able to access a live audio webcast of the present

EpiVax, Inc. (“EpiVax”) a Rhode Island -based company and recognized leader in the field of immunogenicity assessment today announced it has licensed its advanced in silico toolkit for biologics immunogenicity screening, ISPRI, to AbCellera Biologics Inc. (“AbCellera”).

NOCD, a telehealth company that specializes in identifying and treating people with obsessive-compulsive disorder (OCD), announced today the publication in the journal, Behavior Therapy, of a study from Columbia University Medical Center and the New York State Psychiatric Institute on the use of the Company’s mobile app.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced a change in the format and location of its 2020 Annual Meeting of Shareholders. In light of the continued public health concerns regarding the COVID-19 pandemic, and to protect the health of our shareholders, employees and other attendees, the Annual Meeting will be held

Sherlock Biosciences and Integrated DNA Technologies (IDT) today announced the companies have entered into a strategic collaboration to enable large-scale manufacturing of the Sherlock™ CR

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced that cGMP Validation, the company’s cGMP consultant, has completed its post manufacturing audit of the manufacturing facility in Thailand and that the facility has successfully passed the audit. This f

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX:TMD ) ( Nasdaq:TMDI ), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“ MIS ”), is pleased to announce today that it has entered into definitive agreements with a single healthcare-foc

In the initial scramble to quell the impact of the COVID-19 pandemic, the rapid antibody test market was been flooded. Not all tests are created equal and the COVID-19 crisis introduced the opportunity to try unproven players in rapid diagnostic testing.

March of Dimes announces three young investigators as recipients of the 2020 Basil O’Connor Starter Scholar Research Awards: Dr. Ripla Arora from Michigan State University, Dr. Corina Lesseur from Icahn School of Medicine at Mount Sinai and Dr. Jamie Lo from Oregon Health & Science University.